ABBOTT LABORATORIES
ABT · SEC filer number (CIK) 0000001800 · figures from FY2025
The last reported year
Revenue
$44.3B
+5.7% on the year before
Operating margin
18.2%
Net income
$6.5B
Return on invested capital
10.2%
Operating profit after tax
Read from this company's 10-K, filed 2026-02-20. See the filing on EDGAR
Six years
| Year | Revenue | Operating income | Net income |
|---|---|---|---|
| FY2025 | $44.3B | $8.1B | $6.5B |
| FY2024 | $42.0B | $6.8B | $13.4B |
| FY2023 | $40.1B | $6.5B | $5.7B |
| FY2022 | $43.7B | $8.4B | $6.9B |
| FY2021 | $43.1B | $8.4B | $7.1B |
| FY2020 | $34.6B | $5.4B | $4.5B |
Each year is shown as the company first reported it. None of these has been republished with a different number in a later filing.
The rest of the research
Materiality reads ABT's filings in full: every statement line with the concept it was tagged under, the ratios above across twenty years, cash flow, segment and dividend history, insider and institutional ownership, and a written analysis built only from the figures on the page.
Open the full research